>So all entry price are set up that day.
Ah! Bad timing for Ike.
>WARSAW, Ind., July 6 (Reuters) - Medical device maker Biomet Inc <BMET.O> said on Thursday its board declared a three-for-two split of its common stock and earnings before charges rose 22 percent on growth in its reconstructive, spinal and other product lines.
Biomet reported net income of $50.6 million, or 28 cents per diluted share after the stock split, for the fourth quarter ended May 31, versus about $41.6 million, or 23 cents, in the year-ago quarter excluding one-time items.
The company posted earnings of nine cents per share including charges in the year-ago fourth quarter.
Before the stock split, Biomet reported earnings of 42 cents per share. Wall Street expected the Warsaw, Ind.-based company to earn 41 cents per share for the fourth quarter, according to research firm First Call/Thomson Financial.
Biomet's net sales hit $250.2 million in the quarter, versus $223.8 million in the year-ago period.
The company said the new shares from the stock split would be distributed on about August 8 to shareholders of record as of July 18.
The company also said it expected its tax rate to be 34 percent to 35 percent during fiscal year 2001 because of a reduction in the effective tax rate in the United Kingdom and restructuring and tax planning in the United States.
Shares of Biomet closed at 38 on the Nasdaq on Wednesday, down 1-13/16 on the day. The stock has a one-year high of 44-1/2, and a one-year low of 24-5/8.
00:58 07-06-00 |
